Common Contracts

Asset purchase and licensing agreement for stem cell technology

Asset Purchase and Licensing Agreement • February 12th, 2022 • New York

• Contract Type
  Asset Purchase and Licensing Agreement
• Filed
  February 12th, 2022
• Jurisdiction
  New York

This technology, which has generated preliminary data showing the potential to generate monocyte derived islet cells from peripheral blood mononuclear cells, was in early preclinical development at Opexa.